Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,592.95
(
-0.04%
)
News Focus
News Focus
Post# of 447475
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sts66

Send PM Follow Ignore
Followers 74
Posts 15870
Boards Moderated 0
Alias Born 04/26/2010

sts66

Re: marjac post# 260556

Thursday, 04/02/2020 3:49:47 PM

Thursday, April 02, 2020 3:49:47 PM

Post# of 447475
I still don't see how settling now helps them out - as it stands MARINE patents are invalid - AMRN could settle with the 3 generics involved in this case but it doesn't stop any other drug company from filing an ANDA - it doesn't even have to be another generic maker, PFE could submit an ANDA - only way to protect R-IT sales is to get the ruling reversed.

The Thought Police: To censor and protect. Craig Bruce

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News